Company Info
| Phone: | (206) 237-1030 |
| Year Established: | 2003 |
| Ticker: | ZMME |
| Exchange: | NYSE |
Contacts
| Primary: | Kenneth Galbraith Chair & CEO |
| Other: | Chris Astle
PhD Senior VP, CFO Paul Moore PhD CSO Daniel Dex JD General Counsel Lucas Donigian Executive Director, Business Development |
Company Description
Zymeworks is a clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
